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Oncological disease has an enormous impact on patients, their 
families, and the social environment. The main problems the subject 
faces are the constant need to modify reality to adapt to a changing and 
unpredictable situation, dealing with uncertainty, and managing pain. 
Interventions based on mindfulness have been shown to be 
effective in combating these symptoms (Branstrom et al., 2012; 
Cramer et al., 2012; Hoffman et al., 2012; Labelle et al., 2015; Piet 
et al., 2012; Shennan et al., 2011) in both newly diagnosed and 
advanced disease patients (Chambers et al., 2016). In the words of 
Carlson (2016), these programs adapted to cancer represent a form 
of emotion-focused coping that will allow the individual to deal 
with uncertainty and learn to accept his/her inability to control or 
change the course of the disease (Ott et al., 2006).
The two main mindfulness-based interventions that are 
specifi cally designed for oncological patients follow the 
Mindfulness-Based Stress Reduction (MBSR) program, but 
each enriches it with subtly different elements. The fi rst is the 
Mindfulness Based Cancer Recovery (MBCR) (Carlson et al., 
2010). Although its principles are the same as the Kabat-Zinn 
program, it differs in that the authors have included specifi c 
material about how to address cancer. Greater emphasis is placed 
on symptoms such as pain, anticipatory nausea, fear, and diffi cult 
emotions. This program has been effective in reducing symptoms 
such as stress (Carlson et al., 2001), sleep problems (Garland et al., 
2014), and pain (Poulin et al., 2016), and in improving quality of 
life (Henderson et al., 2012). 
The other specifi c protocol for cancer, and the object of this 
study, is Bartley’s Mindfulness-Based Cognitive Therapy (MBCT) 
(Bartley, 2012). It is a program based on the MBCT by Teasdale 
et al (2000) for depression, but it incorporates the coping scheme 
proposed by Moorey and Greer (1983) and contributes the three 
circles model. The coping scheme proposed by O’Brien and 
Moorey (2010) considers the capacity for adaptation, the emotional 
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Abstract Resumen
Objectives: The aim of this study is to analyse whether MBCT will reduce 
the general level of psychopathology, increase the quality of life, and 
increase meta-knowledge about their emotional state in Spanish participants 
with cancer. Method: The sample consisted of n = 88 Spanish oncology 
patients. This was a non-randomized, two-group (experimental vs waiting 
list) trial conducted in a naturalistic setting.  We evaluated psychological 
distress (BSI-18), quality of life (FACT-G), and meta-knowledge of 
emotions (TMMS-24). Results: The participants who received the MBCT 
treatment improved  more than the control group in distress (F= 6.79; p 
= .01, BSI-18), depression (F= 8.38; p = .005 ), quality of life -physical 
health (F = 5.56; p = .02), emotional state (F = 7.06; p= .01),  and functional 
capacity (F = 7.98; p = .006), as well as meta-knowledge about their 
emotional state (F = 35.4; p = .01), and its subscales of perception, (F 
= 8.95; p = .004), comprehension, (F= 16.06; p = .01), and repair  (F = 
15.67; p = .01). Conclusions: The Bartley MBCT program was feasible 
and showed promise in improving general psychopathology (depression), 
improving patients’ quality of life, and increasing meta-knowledge about 
their emotional state.
Keywords: Mindfulness; cancer; Bartley protocol; quality of life; 
Mindfulness-based cognitive therapy.
Terapia Cognitiva Basada en Mindfullness en Pacientes Oncológicos 
Españoles: el Protocolo Bartley. Objetivos: el objetivo de este estudio 
es analizar el papel de la MBCT en la reducción de la psicopatología, la 
mejora de la calidad de vida y del metaconocimiento del estado emocional 
en participantes españoles oncológicos. Método: la muestra consta de n 
= 88 pacientes oncológicos españoles. Este es un ensayo no aleatorio de 
dos grupos (experimental versus lista de espera) realizado en un entorno 
hospitalario. Se evaluaron distrés psicológico (BSI-18), calidad de vida 
(FACTG) y metaconocimiento de las emociones (TMMS). Resultados: 
los participantes con tratamiento MBCT mejoraron más que el grupo 
control en distrés (F= 6.79; p = .01), depresión (F= 8.38; p = .005), en 
la calidad de vida asociada a salud física (F = 5.56; p = .02), al estado 
emocional (F = 7.06; p= .01) y a la capacidad funcional personal (F = 7.98; 
p = .006), y en metaconocimiento de las emociones (F = 35.4; p = .01), y 
sus subescalas percepción (F = 8.95; p = .004), comprensión, (F= 16.06; p 
= .01) y reparación  (F = 15.67; p = .01). Conclusiones: la MBCT mostró 
resultados prometedores para mejorar la psicopatología general, la calidad 
de vida y el metaconocimiento sobre el estado emocional.
Palabras clave: Mindfulness; cancer; protocol Bartley; regulación 
emocional; Terapia Cognitiva Basada en Mindfulness.
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response, and the coping styles that oncological patients put into 
practice when they fi nd out their diagnosis or the state of their 
illness. Depending on how s/he interprets it (as a challenge, loss, or 
threat), the patient will react with fear, anger, sadness, depression, 
or guilt, which, in turn, will activate a specifi c coping style (fi ghting 
spirit, hopelessness, anxious worry, fatalism, or avoidance) and, 
consequently, a greater or lesser perception of control. In addition 
to this survival scheme, Bartley (2012) proposes the three circles 
model: suffering, practice, and presence. 
The circle of suffering shows how the patient is trapped by 
the disease and the main reactions as a consequence: avoidance, 
rumination, trauma and distress, along to the tendency of focusing 
only on the stressful symptoms (Bartley, 2012). The circle of practice 
puts the focus on attentive awareness, through four movements: 1) 
intention, 2) taking a step back, 3) moving towards diffi culty, and 
4) kindness (Bartley, 2016). Any diffi cult situation of the patient is 
used, integrating any physical sensations, emotions, thoughts, and 
actions. The third circle, regarding presence, focuses more on the 
Self rather than on Doing. As the individual practices, s/he begins 
to be able to integrate all that s/he has learned, achieving a greater 
connection with the self and with others (Bartley, 2016). 
Several studies of different MBCT have been carried out with 
cancer patients, including a number of randomized studies. Benefi ts 
have been found in dealing with common experiences related 
to the cancer diagnosis, treatment, and survival, including loss 
of control, uncertainty about the future, and fears of recurrence, 
as well as a range of physical and psychological symptoms, 
including depression, anxiety, insomnia, and fatigue (Chambers et 
al., 2016; Compen et al., 2015; Kingston et al., 2015; Ott et al., 
2006). Specifi cally, several previous studies have demonstrated the 
effectiveness of MBCT in oncology settings. The study by Foley 
et al. (2010) provided evidence supporting the use of MBCT in an 
oncological population. They found signifi cant improvements in 
mindfulness, depression, anxiety, and distress in MBCT participants 
compared to those who had not received the training. Van der Lee 
and Garssen (2012) carried out a study whose aim was to evaluate 
the effi cacy of MBCT group therapy in reducing severe chronic 
fatigue in cancer survivors with different types of cancer diagnoses. 
The subjective feeling of fatigue participants experienced during 
the previous week was signifi cantly lower in the intervention group 
than in the waiting list group. Likewise, Stafford et al. (2013), in 
a study of an MBCT intervention (eight weekly two-hour therapy 
sessions), found that the MBCT intervention was associated with 
signifi cant improvements in distress, quality of life, post-traumatic 
growth, and care, and post-treatment follow-up showed that these 
gains were maintained three months after treatment completion. 
Moreover, Johannsen et al. (2016) assessed the effi cacy of MBCT 
and suggested that MBCT could be a useful pain rehabilitation 
strategy for breast cancer patients. Furthermore, in research 
conducted by Vaziri et al., (2017), 16 women with breast cancer 
received eight two-hour sessions (one session per week) of MBCT 
versus wait-list. The intervention group showed a signifi cant 
reduction in the use of strategies to regulate maladaptive cognitive 
emotions. However, no signifi cant differences were observed in 
the increase in adaptive cognitive emotion regulation strategies 
and the decrease in clinical symptoms between the intervention 
and control groups. Park et al. (2017) showed that MBCT was well 
accepted by Japanese breast cancer patients and had a favourable 
effect on patients’ psychological state and quality of life. Toivonen 
et al. (2017) found that two web-based MBCT programs for cancer 
patients, compared to wait-list, were effective in improving mood, 
psychological distress, and fatigue. A recent meta-analysis (Zhang 
et al., 2019) found benefi cial effects of MCBT interventions on 
quality of life in breast cancer patients compared to the control 
group.
However, despite results suggesting the effi cacy of MBCT, 
a recent meta-analysis of RCT studies about MBCT and MBSR 
interventions with cancer patients and survivors (Cillessen et al., 
2019) showed that these interventions had a statistically signifi cant 
effect on psychological distress (Hedges’s g: 0.32), as well as 
on symptoms of anxiety, depression, fear of cancer recurrence, 
and fatigue (Hedges’s g range:0.29-0.51) at post-intervention. 
Moreover, Cillessen et al. (2019) found no effects of MBCT/MBSR 
on measures of cancer-related quality of life or post-traumatic stress 
symptoms. In the same way, Haller et al. (2017) found evidence 
for statistically signifi cant short-term effects of MBSR and MBCT, 
compared to usual care, on stress, anxiety, depression, and quality 
of life, but with small effect sizes, and average effects did not reach 
minimal clinically important differences. 
In summary, in spite of the evidence of the effectiveness 
of MBCT-based interventions with participants with cancer in 
different countries, as far as we know, there are no studies with 
Spanish participants with cancer. The aim of this study was to 
analyse whether MBCT would reduce the general level of patients’ 
psychopathology, increase their quality of life, and increase meta-




The inclusion criteria for participants were: men and women 
over 18 years of age with a diagnosis of cancer; FVIO patients in 
cancer stages I-III who had fi nished active treatment (chemotherapy, 
radiotherapy, and/or surgery); the presence of psychopathological 
symptoms suggesting psychological distress; and signed informed 
consent. Patients who were assigned to the control group were 
offered the opportunity to participate in the next full awareness 
treatment groups to be held in the coming months. The exclusion 
criteria for the study were: patients undergoing chemotherapy and/
or radiotherapy; patients with a diagnosis of severe mental disorder 
(e.g. schizophrenia, bipolar disorder, or a severe personality 
disorder such as borderline personality disorder); or patients with 
advanced physical deterioration. They were previously informed 
of the procedure to be followed and did not receive any fi nancial 
compensation. The sample was recruited between May 2015 and 
May 2017.
The fi nal sample is made up of a total of 88 participants, all 
of them cancer patients at the Foundation Valencian Institute of 
Oncology (FVIO) (78.4% women, n = 69 and 21.6% men, n = 
19), with an average age of 54.92 years (SD = 9.45). Research 
participants are diagnosed with different types of tumours: 48.9% 
breast cancer, n = 43, 9.1% lung cancer, n = 8, 8% uterine and 
urinary cancer, n = 7, 6.8% colon cancer, n = 6, 3.4% prostate, 
ovarian, kidney and skin cancer, n = 3, 2.3% stomach and pancreatic 
cancer, n = 2, and 1.1% bone cancer, n = 1, with an average time 
since the diagnosis of the disease of 40.20 months (SD = 4.18). 
Participants had a diagnosis of cancer of stage I (6%), II (72%), 
or III (22%).
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Instruments
Brief Symptom Inventory 18 (BSI-18; Derogatis & Melisaratos, 
1983). The objective of this inventory is to provide information 
about the level of psychological distress in the general and medical 
population. The person evaluated should indicate the degree of 
discomfort caused by each of the 18 symptoms in the past seven 
days. The scores are obtained from a Likert-type scale ranging 
from 0 to 4 (0 = nothing and 4 = a lot). A Global Severity Index 
is obtained from the sum of the 18 items, and it ranges from 0 
to 72. The items are grouped in the following three subscales: 
somatization (items 1, 4, 7, 10, 13 and 16), depression (items 2, 
5, 8, 11, 14 and 17), and anxiety (items 3, 6, 9, 12, 15 and 18). 
This instrument has high internal consistency (α = 0.89) and has 
been validated in Spanish (Galdón et al., 2008). In our sample, the 
reliabilities were: Somatization (α = 0.75); depression (α = 0.89); 
anxiety (α = 0.83); BSI total (α = 0.84).
Functional Assessment of Cancer Therapy - General (FACT-G; 
Cella et al., 1993) is an instrument that was designed for self-
application or for use in a clinical interview. Its objective is to 
measure the quality of life of the oncology patient in general. 
This tool consists of a total of 27 items grouped in the following 
dimensions: general physical health situation, family and social 
environment, emotional state, and capacity for personal functioning. 
It is scored on a Likert-type scale (0 = nothing and 4 = a lot). 
Some of the items are presented in the opposite direction (items 
on the family and social environment and capacity for personal 
functioning subscales). This questionnaire is characterized by high 
reliability (Cronbach alpha close to 0.9). We used the Spanish 
version (Cella et al., 1993). In our sample, the reliabilities were 
adequate for the FACTG total ( α = 0.81), and for the subscales: 
FACTG physical health (α = 0.83); FACTG: family and social 
environment (α = 0.78); FACTG emotional state (α = 0.85); 
FACTG personal functioning (α = 0.82). 
Trait-Meta Mood Scale-24 (TMMS-24; Salovey et al., 1995). 
This scale in its original version evaluates meta-knowledge about 
emotional states with 24 items, and it has been validated in Spanish 
(Fernández-Berrocal et al., 2004). The scale is composed of three 
subscales containing 8 items each: emotional attention or perception, 
emotional clarity or understanding, and emotional repair or regulation. 
In the Spanish validation (Fernández-Berrocal et al., 2004), the 
internal consistency of the subscales was high (all Cronbach alphas 
were above 0.85). In our sample, the reliabilities were: Emotional 
attention (α = 0.76); Emotional perception (α = 0.84); Emotional 
regulation (α = 0.85); and TMMS total (α = 0.86).
Procedure
This is a non-randomized, two-group (experimental vs waiting 
list) trial conducted in a naturalistic setting. Naturalistic studies 
(effectiveness studies) are carried out under the conditions of 
clinical practice. Based on previous studies on psychological 
interventions in heterogeneous populations of patients with 
cancer, an effect size of 0.39 for anxiety and 0.35 for depression 
is expected (Guarino et al., 2020). Because our design includes 
two experimental conditions, and considering an α = 0.05 and a 
statistical power of 0.80 on a 2-tailed t test, the total sample size 
needed is about 90 participants (45 participants per experimental 
condition). These calculations were made with the software 
program G*Power 3.1 (Faul et al., 2007). 
Two weeks before the beginning of therapy, the psychologist 
offered the patient the possibility of participating in the study. Thus, 
159 participants were consulted, and n = 88 agreed to participate 
and fi lled in the BSI-18, FACT-G, and TMMS questionnaires 
on the fi rst day (pre-test). The reason 71 participants refused 
to participate in the study was that the group intervention was 
held in the morning, and this timetable was incompatible with 
their job or family activities. At pre-treatment, the sample was 
composed of 88 patients, n = 47 in the wait list condition and 
n = 41 in the experimental condition. In the wait list condition, 
therefore, four patients dropped out during the two months because 
of illness (e.g., medical complications or change in hospital for 
medical treatment), and so at the end of the process, n = 43. In 
the experimental condition, nine patients dropped out because of 
illness, and so n = 32 at the end of the treatment. This information 
is displayed in the following scheme according to the CONSORT 
group (See fi gure 1). 
The participants completed three measurement instruments at 
both the beginning and end of treatment, in order to be able to 
verify and evaluate the results after implementing the intervention 
based on full awareness. Information about the diagnosis of mental 
disorders, previous surgery, chemotherapy and / or radiotherapy 
treatments, or advanced physical deterioration was obtained from 
the clinical history of the participants. The study was approved by 
the ethics committees of the FVIO.
For the experimental condition, participants who were receiving 
psychological treatment for cancer were consecutively selected, 
and for the wait list condition, participants who were waiting to 
initiate the psychological treatment were consecutively selected. 
The time between the pre-treatment and posttreatment evaluations 
in the experimental condition was two months, and the time 
between the two evaluations (T1T2) in the wait list condition was 
also two months. 
The program conducted in this study consists of a full care 
training treatment based on the Bartley Protocol (2012). The 
program was applied in groups composed of 15 participants. In 
this eight-week intervention offered to patients, different aspects 
of the disease process are addressed: awareness, facing obstacles, 
familiarization with the body and feelings, encouraging kindness, 
and taking care of oneself. For this purpose, different techniques 
are used: various types of meditation, full attention through the 
body scan, the raisin exercise, the pause exercise, or the experience 
map, among others. Each session has an approximate duration of 
two and a half hours (one per week), with a follow-up session 
one month after the end of therapy. Throughout the treatment, the 
patients had audio recordings with which they could practice full 
day-to-day care. In each session, the performance on the previous 
week’s homework was evaluated. The treatment was administered 
by two expert MCBT therapists with more than 10 years of 
experience in the evaluation and treatment of patients with cancer. 
Thus, each therapist monitored adherence to the original MBCT 
protocol by the other therapist. 
As explained above, Bartley (2012) proposes the three circles 
model in her mindfulness program. In the fi rst session, the circle 
of suffering is explained in order to identify the main diffi culties 
that arise when facing cancer. Mindfulness is explained by using 
the classic raisin exercise, and the body-scan and pause practices 
are introduced. The second session teaches participants to use 
the experience map as a cognitive record of everyday situations, 
starting with pleasant situations and then moving on to unpleasant 
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ones. The third week is dedicated to familiarizing participants with 
breathing and body movement, teaching them to work with their 
own personal boundaries in a courageous, gentle, and sensitive 
manner, and returning to breathing whenever they need to. In this 
session, they learn the Three Minute Breathing Space. The central 
theme of the fourth session is to learn to respond to experience 
in a gentle way. For this purpose, they are taught to recognize 
their way of reacting impulsively, especially the mental patterns 
of cavitation and anxiety, and to return to the direct sensations of 
the body and breathing. The fi fth session introduces the circle of 
practice. It illustrates the movements or gestures patients learn 
during the course (Intention, Coming Back, Turning Towards, and 
Kindness), so that they learn to relate to their problematic patterns 
(Physical Sensations, Thoughts, Feelings, and Actions). It is a 
moment of courage and bravery, as cancer patients are afraid to 
focus on their own fears and physical sensations with openness 
and kindness because they interpret any physical discomfort as a 
sign of recurrence. Therefore, in this session, the patient has to stop 
and observe the mental patterns that cause his/her suffering and 
observe them in a mindful and compassionate way. The practice of 
The Physical Barometer linked to the Pause is very useful in this 
session. The aim of the sixth week is for participants to learn to 
accept that thoughts are transient, empty, and impersonal, although 
some are linked to feelings. In the seventh week, patients are 
invited to observe their personal guidelines by listing the nurturing 
and draining daily activities so that they can make decisions that 
encourage well-being, both now and in the future. The eighth week 
consists of observing what has been done in the previous weeks 
and committing to a plan of action for the next four weeks. Part of 
this session is dedicated to introducing the third circle, Presence, 
where one begins to appreciate the richness of the experience with 
greater clarity and confi dence, increasing the connection with 
shared humanity. To conclude, the follow-up session that takes 
place one month after the end of the eight sessions consists of a 
Participants evaluated (N = 159)
Refused to participate (n = 71)
Participants assigned to the two
treatment conditions (n = 88)
Condition:  Waist list
 (n = 47)
Drop outs (n= 4)
Causes: (n = 4) Lost because of illness
Condition: Bartley Protocol
 (n = 41)
Drop outs (n = 9)
Causes: (n = 9) Lost because of illness
Analysis (n = 43)
Exclusions from





















Figure 1. Sample evolution throughout treatment
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daily review and action plans. Its aim is to continue to encourage 
the practice of mindfulness and kindness in everyday life. Self-
reports and tasks were collected and reviewed weekly during the 
MCBT sessions.
Data analysis 
First, with the aim of verifying whether there were statistically 
signifi cant differences between the two conditions (experimental 
vs waiting list), Student’s t-test for independent samples was 
performed for continuous variables and chi-squares for categorical 
variables. Subsequently, an analysis of variance (ANOVA) of 
repeated measures was performed to check whether there were 
statistically signifi cant differences between the two experimental 
conditions at the end of treatment. 
Results
The results show that there were no differences between the 
experimental conditions before beginning the intervention on: 
Types of tumours (χ2 = 15.33; p =.17), gender (χ2 = 0.01, p = .939), 
age (t
(86)
 = 0.41; p = .67), and time since the diagnosis of the disease 
(t
(86)
 = -0.13; p = .89). 
Regarding the BSI-18 before starting treatment, the experimental 
condition had higher scores than the wait list condition on the BSI 
total score (t
(86)
 = -3,78; p < .01) and on each of its subscales: 
somatization (t
(86)
= -3.25; p < .01), depression (t
(86)
= -3.36; p < .01), 
and anxiety (t
(86) 
= -3.43; p < .01). Therefore, before receiving any 
type of treatment, the experimental condition had worse scores on 
the level of psychological distress.
Regarding the FACTG, the experimental condition and the 
waiting list condition did not differ on the FACTG total score 
(t
(86)
 = 0.52; p > .05). However, there were statistically signifi cant 
differences on the physical health (t
(86)
= -2.27; p < .02), family and 
social environment (t
(85)
 = 3.58; p < .01), emotional state (t
(86)
 = 
-3.28; p < .01), and personal functioning capacity (t
(85)
 = 2.66; p 
< .01) subscales. On all of them, the experimental condition had 
worse scores than the wait list condition. 
Regarding the TMMS, there were no differences between the 
two conditions on the TMMS total score (t
(85) 
= 0.436; p = .66) or 
on the subscales: emotional perception (t
(85)
 = 2; p = .17), emotional 
comprehension (t
(85)
 = 0.94; p = .34). and emotional regulation (t 
(85)
 = 1.08; p = .28).
As Table 1 shows, on the BSI-18 total score, no statistically 
signifi cant differences were found depending on the time of 
evaluation (pre-post) (F
(1,71)
 = 1.05; p = .31; η2p = .01). However, 
a signifi cant interaction effect was found between the time of 
evaluation and the treatment condition (F
(1,71) 
= 6.79; p = .01; η2p = 
.08). The group that received the treatment improved more than the 
control group. In the same way, on the BSI-18 depression subscale, 
no statistically signifi cant differences were found depending on the 
time of evaluation (pre-post) (F
(1,71)
 = 1.18; p = .28; η2p = .01). 
However, a signifi cant interaction effect was found between the 
time of evaluation and the treatment condition (F
(1,71)
 = 8.38; p = 
.005; η2p = .11). On BSI-18 anxiety, no statistically signifi cant 
differences were found depending on the time of evaluation (pre-
post) (F 
(1,71) 
= 1.18; p = .28; η2p = .01), and no signifi cant interaction 
effect was found (F
(1,71)
 = 3.18; p = .08; η2p = .43). Finally, on BSI-
18 somatization, no statistically signifi cant differences were found 
depending on the time of evaluation (pre-post) (F
(1,71)
 = 0.05; p 
= .82; η2p = .01), and no signifi cant interaction effect was found 
(F
(1,71) 
= 3.21; p = .77; η2p = .43).
No statistically signifi cant differences were found on the 
FACTG total score depending on the time of evaluation (F
(1,71)
 
= 0.21; p = .64; η2p =.01), and no signifi cant interaction effect 
between the treatment conditions was found (F
(1,71)
 = 0.01; p = 
.92; η2p = .01). However, a signifi cant interaction effect between 
treatment conditions was observed for the general physical health 
scale subscale (F
(1,71)
 = 5.56; p = .02; η2p =.07), for the emotional 
state scale subscale (F
(1,71)
 = 7.06; p= .01; η2p =.09), and for the 
personal functioning subscale (F
(1,71) 
= 7.98; p = .001; η2p =.10). 
Finally, on the family and social environment subscale, no 
signifi cant differences were observed in the groups before and after 
treatment, and no interaction effect was found between treatment 
conditions (F
(1,71)
 = 3.50; p = .06; η2p =.05).
Finally, on the TMMS total, there were statistically signifi cant 
differences with regard to the moment of evaluation (pre-post) 
(F
(1,72)
 = 5.67; p = .02; η2p =.07), and a signifi cant interaction effect 
between the moment of evaluation and the treatment condition 
(F
(1,72)
 = 35.40; p = .01; η2p =.33). On TMMS perception, there 
were no statistically signifi cant differences with regard to the 
moment of evaluation (pre-post) (F
(1,72)
 = 2.75; p = .10; η2p =.03), 
but there was a signifi cant interaction effect between the moment 
of evaluation and the treatment condition F
(1,72)
 = 8.95; p = .01; 
η2p =.11). In the same way, on TMMS compression, there were 
statistically signifi cant differences with regard to the moment 
of evaluation (pre-post) (F
(1,72)
 = 6.85; p = .01; η2p =.08) and a 
signifi cant interaction effect between the moment of evaluation and 
the treatment condition F
(1,72)
 = 16.06; p = .01; η2p =.18). Finally, 
for TMMS repair, there were statistically signifi cant differences 
with regard to the moment of evaluation (pre-post) (F
(1,72)
 = 8.51; 
p = .01; η2p =.11) and a signifi cant interaction effect between the 
moment of evaluation and the treatment condition (F
(1,72)
 = 15.67; 
p = .01; η2p =.17). All the results are listed in Table 1.
Discussion
The aim of this study was to analyse whether MBCT would 
reduce the general level of patients’ psychopathology, increase 
their quality of life, and increase meta-knowledge about their 
emotional state in Spanish participants with cancer. 
Our results are in line with those from Bondolfi  et al. (2017), 
who found that MBCT had positive effects on depression, 
showing that MBCT increases the average time to relapse by at 
least 18 weeks in participants with a history of recurrent major 
depression. Our results further support previous studies that have 
demonstrated the effectiveness of MBCT in oncology settings 
(Foley et al., 2010; Van der Lee & Garssen 2012; Stafford et al., 
2013; Johannsen et al., 2016; Vaziri et al., 2017; Park et al., 2017; 
Toivonen et al., 2017; Zhang et al., 2019; Cillessen et al., 2019). 
However, with our study, we have taken another step by showing 
that MBCT reduced the general level of patients’ psychopathology 
(depression), increasing quality of life (general physical health, 
emotional state, and personal functioning) and meta-knowledge 
about their emotional state in a naturalistic setting with Spanish 
cancer patients. Naturalistic studies are carried out under the 
conditions of clinical practice, and so they have high clinical 
representativeness (Leichsenring, 2004). Finally, our results 
suggest that, although the most widely used mindfulness-based 
intervention in psycho-oncology is MBSR, oncology patients who 
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score signifi cantly high on depressive symptoms may benefi t from 
being treated with MBCT.
There are several limitations that should be improved in our 
study and could be the starting point for future research. The main 
limitation is that the non-randomization of the sample may lead to 
bias in the selection of participants. Thus, it is not possible to infer 
causal relationships between the independent variable (treatment 
condition) and the dependent variables (BSI-18, FACT-G, and 
TMMS-24 scores), and so it is necessary to perform a randomized 
control trial with the MBCT intervention in Spanish oncological 
patients to confi rm our results. However, in our study, we have 
verifi ed that there are no differences between the two experimental 
conditions in gender, type of tumour, age, and years of evolution 
of the disease before beginning the intervention. There were only 
differences on the BSI-18 and on the level of psychological stress, 
with the experimental condition presenting higher scores. Moreover, 
in our study there is no follow-up to confi rm the differences between 
conditions, as previous study showed benefi cial results over time. 
Stafford et al. (2013), after performing the MBCT intervention, 
found signifi cant improvements in anguish, quality of life, attention, 
and post-traumatic growth, and these gains were maintained at 
follow-up three months after the end of the treatment. An interesting 
proposal would be to follow up patients at both six months and one 
year. This could provide more precise information about whether 
the positive effect of this intervention in this type of patient lasts 
over time. Moreover, our sample is very heterogeneous in the types 
of tumours presented by the participants, and for this reason, the 
generalization of these results to other types of samples is limited. 
Finally, we used the wait list as the control group, and we do not 
have information about the satisfaction and perceived utility of the 
intervention participants. Thus, generic components of group-based 
therapy, such as support, destigmatization, therapeutic attention, and 
emotional expression in the groups, could be responsible for our 
results, and we cannot attribute the change specifi cally to MBCT. 
Table 1
Descriptive statistics at pre and post treatment for the outcome variables in the experimental condition and wait list condition




Pre Post Pre-post Pre-post



















































8.51 .005 .106 15.67 .000 .179
Control 24.56(6.58) 25.88(6.29)
 Note: BSI-18 = Brief Symptom Inventory 18; BSI-18total: total score on BSI-18; BSI-18ans: anxiety scale of BSI-18; BSI-18dep: depression scale of BSI-18; BSI-18som: somatization scale 
of BSI-18; FACTG = Functional Assessment of Cancer Therapy – General; FACTGtotal: total score on the FACTG; FACTGp: general physical health scale of FACTG; FACTGs: family and 
social environment scale of FACTG ; FACTGe: emotional state scale of FACTG; FACTGf: personal functioning scale of FACTG; TMMS = Trait-Meta Mood Scale-24; TMMStotal: total score 
on theTMMS24 ; TMMSp: emotional perception scale of TMMS24; TMMSc: emotional comprehension scale of TMMS24; TMMSr: emotional regulation scale of TMMS24
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A recent meta-analysis of MBCT stated that studies with passive 
control conditions (compared with active/competing conditions) 
reported greater reductions in psychological distress, anxiety, and 
depression at post-intervention (Cillessen et al., 2019). Therefore, 
future studies will have to compare the MBCT intervention with 
other active psychotherapies, such as Meaning-centred group 
psychotherapy (Breitbart et al., 2010) or CBT interventions. 
Moreover, in our study, we cannot analyse the mediators or 
moderators of the results. Previous studies (Cillessen et al., 2019) 
found that age and the comparison condition (active vs passive) were 
signifi cative mediators of the results. Finally, we did not evaluate the 
benefi ts mindfulness produced, and so in future research it would be 
interesting to add to the assessment protocol a specifi c scale that 
evaluates the benefi ts of mindfulness (Barajas & Garra, 2014).
In conclusion, as far as we know, this is the fi rst study to 
administer the MBCT program to Spanish cancer patients, and 
the results suggest that the Bartley MBCT program was feasible 
and showed promise in improving the general status of patients’ 
psychopathology (depression), increasing quality of life (general 
physical health, emotional state, and personal functioning) and 
meta-knowledge about their emotional state. 
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